German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2009

Conditions
Lymphoma, Lymphoblastic
Interventions
DRUG

Dexamethasone/Prednisolone

DRUG

Cyclophosphamide

DRUG

Vincristine

DRUG

Daunorubicin

DRUG

Asparaginase

DRUG

G-CSF

DRUG

Mercaptopurine

DRUG

Cytarabine

DRUG

Methotrexate

DRUG

VP16

DRUG

Vindesine

DRUG

Adriamycin

DRUG

Thioguanine

DRUG

HDARAC

PROCEDURE

CNS irradiation

PROCEDURE

Mediastinal irradiation

DRUG

Cladribine

Trial Locations (1)

60590

University Hospital, Medical Dept. II, Frankfurt

All Listed Sponsors
lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT00199017 - German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults | Biotech Hunter | Biotech Hunter